Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (20164)	3/29/1999 6:09:00 PM
From: Mkilloran	Respond to of 23519

vlad...the UK NHS has request input over a 6 week period...extended it to 8 weeks and now has to come to a conclusion and publish their longer term guidelines. I can see some minor adjustments such as open up the group to include coverage by the NHS on ED patients with diabetes as an example. But overall it's a matter of lack of funds and higher priorities for other medications...nothing in the BBC articles would lead me to believe they have identified new funds or eliminated expenses in other areas to open up coverage for ED patients on the NHS. Waiting for the published report to follow.